QIAstat-Dx Gastrointestinal Panel 2
Rapidly detect common gastrointestinal pathogens to support faster, more informed diagnosis and treatment.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The QIAstat-Dx Gastrointestinal Panel 2 is a multiplexed nucleic acid test for the qualitative detection and differentiation of gastrointestinal pathogens. It is intended for use with the QIAstat-Dx Analyzer and QIAstat-Dx Analyzer 2 systems.
Intended use and clinical application
The QIAstat-Dx Gastrointestinal Panel 2 is a multiplexed nucleic acid test intended for the qualitative detection and differentiation of nucleic acids from multiple gastrointestinal viral, bacterial and parasitic pathogens in human stool specimens collected in Cary-Blair transport medium, from individuals with signs and symptoms of gastrointestinal infection. The test is indicated for use with the QIAstat-Dx Analyzer and QIAstat-Dx Analyzer 2 systems by professional users, such as trained laboratory technicians and clinicians, in clinical laboratories. Results from the QIAstat-Dx Gastrointestinal Panel 2 are intended to be used in conjunction with other clinical, epidemiological and laboratory data to assist in the diagnosis of gastrointestinal infections.
Test method and workflow
The QIAstat-Dx Gastrointestinal Panel 2 is based on real-time polymerase chain reaction (PCR) technology for the amplification and detection of target nucleic acids. Stool specimens collected in Cary-Blair transport medium are loaded into a single-use QIAstat-Dx cartridge, which is then inserted into the QIAstat-Dx Analyzer or QIAstat-Dx Analyzer 2. The system performs automated nucleic acid extraction, amplification and detection, and provides qualitative results for each targeted pathogen on the panel.
Interpretation of results and limitations
QIAstat-Dx Gastrointestinal Panel 2 results are qualitative and indicate the presence or absence of nucleic acids from specific gastrointestinal pathogens in the tested specimen. Detection of pathogen nucleic acid does not necessarily indicate the presence of viable organisms or confirm causation of disease, and negative results do not preclude infection. Test results must be interpreted by healthcare professionals in the context of patient history, clinical signs and symptoms, and other laboratory findings.
Key features and benefits of QIAstat-Dx Gastrointestinal Panel 2:
- Multiplexed real-time polymerase chain reaction (PCR) detection of multiple gastrointestinal pathogens from a single stool specimen
- Fully integrated workflow on the QIAstat-Dx Analyzer and QIAstat-Dx Analyzer 2 with automated extraction, amplification and detection
- Qualitative results that support rapid clinical decision-making for suspected gastrointestinal infections
- Use with stool specimens collected in Cary-Blair transport medium for standardized sample handling
- Designed for professional use in clinical laboratories, supporting consistent and reliable diagnostic testing
